Log In
BCIQ
Print this Print this
 

Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)

BCIQ
Print ChartPrint this
Marketed, 4 Phase III, 1 Phase II, 2 Phase II, 1 Phase II, 1 Phase II, 7 Phase I/II, 1 Phase I/II, 2 Phase I, 1 Phase I, 1 Phase I, 5 Phase I, 1 Preclinical, 1 Preclinical, 1 Preclinical, 4
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIMarketed
Autoimmune

-

1

-

-

-

-

Cancer

4

5

2

7

1

-

Endocrine / Metabolic

-

-

-

1

-

4

Musculoskeletal

1

-

-

-

-

-

Neurology

1

1

1

1

-

-

Ophthalmic

-

1

-

2

-

-




 Products Targeting Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today